Mathias Hukkelhoven
Director/Board Member presso COMPUGEN LTD.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Mathias Hukkelhoven is an Independent Director at Compugen Ltd.
and an Independent Non-Executive Director at Centessa Pharmaceuticals Plc.
He previously worked as the Chairman-Portfolio Stewardship at Novartis Pharmaceuticals Corp.
and as the Senior VP-Global Head Drug Regulatory Affairs at Novartis Pharmaceuticals Corp.
from 2001 to 2009.
He also served as the SVP-Global Regulatory, Safety & Biometrics at Bristol-Myers Squibb (Israel) Ltd.
from 2010 to 2021.
Dr. Hukkelhoven obtained his undergraduate and doctorate degrees from Radboud University Nijmegen.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 19/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Mathias Hukkelhoven
| Società | Posizione | Inizio |
|---|---|---|
| COMPUGEN LTD. | Director/Board Member | 01/03/2022 |
| CENTESSA PHARMACEUTICALS PLC | Director/Board Member | 01/07/2022 |
Precedenti posizioni note di Mathias Hukkelhoven
| Società | Posizione | Fine |
|---|---|---|
| Bristol-Myers Squibb (Israel) Ltd. | General Counsel | 01/07/2021 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | General Counsel | 01/01/2009 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - |
Formazione di Mathias Hukkelhoven
| Radboud University Nijmegen | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| COMPUGEN LTD. | Health Technology |
| CENTESSA PHARMACEUTICALS PLC | Health Technology |
| Aziende private | 2 |
|---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
| Bristol-Myers Squibb (Israel) Ltd. |
- Borsa valori
- Insiders
- Mathias Hukkelhoven
